{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:58:52Z","timestamp":1793289532968,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RC 124 Funginet Project C4"],"award-info":[{"award-number":["RC 124 Funginet Project C4"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RC 124 Funginet Project C6"],"award-info":[{"award-number":["RC 124 Funginet Project C6"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC 124 Funginet project C4"],"award-info":[{"award-number":["CRC 124 Funginet project C4"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SK 46\/2-2"],"award-info":[{"award-number":["SK 46\/2-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Persistent inflammation is a hallmark of many human diseases, including anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) and atherosclerosis. Here, we describe a dominant trigger of inflammation: human serum factor H-related protein FHR1. In vitro, this protein selectively binds to necrotic cells via its N-terminus; in addition, it binds near necrotic glomerular sites of AAV patients and necrotic areas in atherosclerotic plaques. FHR1, but not factor H, FHR2 or FHR3 strongly induces inflammasome NLRP3 in blood-derived human monocytes, which subsequently secrete IL-1\u03b2, TNF\u03b1, IL-18 and IL-6. FHR1 triggers the phospholipase C-pathway via the G-protein coupled receptor EMR2 independent of complement. Moreover, FHR1 concentrations of AAV patients negatively correlate with glomerular filtration rates and associate with the levels of inflammation and progressive disease. These data highlight an unexpected role for FHR1 during sterile inflammation, may explain why FHR1-deficiency protects against certain diseases, and identifies potential targets for treatment of auto-inflammatory diseases.<\/jats:p>","DOI":"10.1038\/s41467-019-10766-0","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T10:18:10Z","timestamp":1562235490000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Serum FHR1 binding to necrotic-type cells activates monocytic inflammasome and marks necrotic sites in vasculopathies"],"prefix":"10.1038","volume":"10","author":[{"given":"Sarah","family":"Irmscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke R.","family":"Brix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svante L. H.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke D.","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Mutlut\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaldas","family":"Girdauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Reichenspurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf A. K.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berit","family":"Jungnickel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Wiech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-2411","authenticated-orcid":false,"given":"Peter F.","family":"Zipfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2374-6473","authenticated-orcid":false,"given":"Christine","family":"Skerka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"10766_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1681\/ASN.2006091021","volume":"18","author":"M Chen","year":"2007","unstructured":"Chen, M. et al. Antineutrophil cytoplasmic autoantibody-negative Pauci-immune crescentic glomerulonephritis. J. Am. Soc. Nephrol.: JASN 18, 599\u2013605 (2007).","journal-title":"J. Am. Soc. Nephrol.: JASN"},{"key":"10766_CR2","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.hlc.2013.01.012","volume":"22","author":"F Zheng","year":"2013","unstructured":"Zheng, F., Xing, S., Gong, Z. & Xing, Q. NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis. Heart, lung Circ. 22, 746\u2013750 (2013).","journal-title":"Heart, lung Circ."},{"key":"10766_CR3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.atherosclerosis.2017.10.027","volume":"267","author":"M Baldrighi","year":"2017","unstructured":"Baldrighi, M., Mallat, Z. & Li, X. NLRP3 inflammasome pathways in atherosclerosis. Atherosclerosis 267, 127\u2013138 (2017).","journal-title":"Atherosclerosis"},{"key":"10766_CR4","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","volume":"18","author":"JS Roh","year":"2018","unstructured":"Roh, J. S. & Sohn, D. H. Damage-associated molecular patterns in inflammatory diseases. Immune Netw. 18, e27 (2018).","journal-title":"Immune Netw."},{"key":"10766_CR5","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi, J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660\u2013665 (2015).","journal-title":"Nature"},{"key":"10766_CR6","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1126\/science.aaf3036","volume":"352","author":"I Zanoni","year":"2016","unstructured":"Zanoni, I. et al. An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells. Science 352, 1232\u20131236 (2016).","journal-title":"Science"},{"key":"10766_CR7","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.immuni.2017.11.013","volume":"48","author":"CL Evavold","year":"2018","unstructured":"Evavold, C. L. et al. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity 48, 35\u201344 (2018).","journal-title":"Immunity"},{"key":"10766_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fimmu.2011.00062","volume":"2","author":"L Bosurgi","year":"2011","unstructured":"Bosurgi, L., Manfredi, A. A. & Rovere-Querini, P. Macrophages in injured skeletal muscle: a perpetuum mobile causing and limiting fibrosis, prompting or restricting resolution and regeneration. Front. Immunol. 2, 62 (2011).","journal-title":"Front. Immunol."},{"key":"10766_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette, J. C. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 65, 1\u201311 (2013).","journal-title":"Arthritis Rheum."},{"key":"10766_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel, P. F. & Skerka, C. Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9, 729\u2013740 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"10766_CR11","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1182\/blood-2009-02-205641","volume":"114","author":"S Heinen","year":"2009","unstructured":"Heinen, S. et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114, 2439\u20132447 (2009).","journal-title":"Blood"},{"key":"10766_CR12","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1016\/S0021-9258(18)99058-7","volume":"266","author":"C Skerka","year":"1991","unstructured":"Skerka, C., Horstmann, R. D. & Zipfel, P. F. Molecular cloning of a human serum protein structurally related to complement factor H. J. Biol. Chem. 266, 12015\u201312020 (1991).","journal-title":"J. Biol. Chem."},{"key":"10766_CR13","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3389\/fimmu.2017.01328","volume":"8","author":"AE van Beek","year":"2017","unstructured":"van Beek, A. E. et al. Factor H-Related (FHR)-1 and FHR-2 Form Homo- and Heterodimers, while FHR-5 Circulates Only As Homodimer in Human Plasma. Front. Immunol. 8, 1328 (2017).","journal-title":"Front. Immunol."},{"key":"10766_CR14","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1073\/pnas.1219260110","volume":"110","author":"E Goicoechea de Jorge","year":"2013","unstructured":"Goicoechea de Jorge, E. et al. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc. Natl Acad. Sci. USA 110, 4685\u20134690 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10766_CR15","doi-asserted-by":"publisher","first-page":"18054","DOI":"10.1074\/jbc.271.30.18054","volume":"271","author":"CT Park","year":"1996","unstructured":"Park, C. T. & Wright, S. D. Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein A-I, phospholipid, and factor H-related proteins. J. Biol. Chem. 271, 18054\u201318060 (1996).","journal-title":"J. Biol. Chem."},{"key":"10766_CR16","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ng.787","volume":"43","author":"AG Gharavi","year":"2011","unstructured":"Gharavi, A. G. et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat. Genet. 43, 321\u2013327 (2011).","journal-title":"Nat. Genet."},{"key":"10766_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1038\/ng1890","volume":"38","author":"AE Hughes","year":"2006","unstructured":"Hughes, A. E. et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 38, 1173\u20131177 (2006).","journal-title":"Nat. Genet."},{"key":"10766_CR18","doi-asserted-by":"publisher","first-page":"e1002079","DOI":"10.1371\/journal.pgen.1002079","volume":"7","author":"J Zhao","year":"2011","unstructured":"Zhao, J. et al. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet. 7, e1002079 (2011).","journal-title":"PLoS Genet."},{"key":"10766_CR19","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1371\/journal.pgen.0030041","volume":"3","author":"PF Zipfel","year":"2007","unstructured":"Zipfel, P. F. et al. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 3, e41 (2007).","journal-title":"PLoS Genet."},{"key":"10766_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41418-018-0218-0","volume":"26","author":"A Linkermann","year":"2019","unstructured":"Linkermann, A. Death and fire-the concept of necroinflammation. Cell death Differ. 26, 1\u20133 (2019).","journal-title":"Cell death Differ."},{"key":"10766_CR21","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/nature10449","volume":"478","author":"D Weismann","year":"2011","unstructured":"Weismann, D. et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478, 76\u201381 (2011).","journal-title":"Nature"},{"key":"10766_CR22","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/j.1462-5822.2006.00751.x","volume":"8","author":"SL Fink","year":"2006","unstructured":"Fink, S. L. & Cookson, B. T. Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages. Cell. Microbiol. 8, 1812\u20131825 (2006).","journal-title":"Cell. Microbiol."},{"key":"10766_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/356768a0","volume":"356","author":"NA Thornberry","year":"1992","unstructured":"Thornberry, N. A. et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356, 768\u2013774 (1992).","journal-title":"Nature"},{"key":"10766_CR24","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz, P. & Dixit, V. M. Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16, 407\u2013420 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"10766_CR25","doi-asserted-by":"publisher","first-page":"e1526","DOI":"10.1038\/cddis.2014.488","volume":"5","author":"M Aziz","year":"2014","unstructured":"Aziz, M., Jacob, A. & Wang, P. Revisiting caspases in sepsis. Cell death Dis. 5, e1526 (2014).","journal-title":"Cell death Dis."},{"key":"10766_CR26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3389\/fimmu.2017.00373","volume":"8","author":"K-Y I","year":"2017","unstructured":"I, K.-Y. et al. Activation of adhesion GPCR EMR2\/ADGRE2 induces macrophage differentiation and inflammatory responses via G\u03b116\/Akt\/MAPK\/NF-\u03baB Signaling pathways. Front. Immunol. 8, 373 (2017).","journal-title":"Front. Immunol."},{"key":"10766_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature11588","volume":"492","author":"G-S Lee","year":"2012","unstructured":"Lee, G.-S. et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+and cAMP. Nature 492, 123\u2013127 (2012).","journal-title":"Nature"},{"key":"10766_CR28","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1073\/pnas.96.11.6353","volume":"96","author":"MK Chang","year":"1999","unstructured":"Chang, M. K. et al. Monoclonal antibodies against oxidized low-density lipoprotein bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages: evidence that oxidation-specific epitopes mediate macrophage recognition. Proc. Natl Acad. Sci. USA 96, 6353\u20136358 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10766_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.7861\/clinmedicine.17-1-60","volume":"17","author":"M Yates","year":"2017","unstructured":"Yates, M. & Watts, R. ANCA-associated vasculitis. Clin. Med. (Lond., Engl.) 17, 60\u201364 (2017).","journal-title":"Clin. Med. (Lond., Engl.)"},{"key":"10766_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00395-011-0192-x","volume":"106","author":"W Martinet","year":"2011","unstructured":"Martinet, W., Schrijvers, D. M., De, Meyer & Guido, R. Y. Necrotic cell death in atherosclerosis. Basic Res. Cardiol. 106, 749\u2013760 (2011).","journal-title":"Basic Res. Cardiol."},{"key":"10766_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/MNH.0b013e3283456731","volume":"20","author":"JC Jennette","year":"2011","unstructured":"Jennette, J. C., Falk, R. J. & Gasim, A. H. Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr. Opin. Nephrol. Hypertens. 20, 263\u2013270 (2011).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10766_CR32","doi-asserted-by":"publisher","first-page":"e60352","DOI":"10.1371\/journal.pone.0060352","volume":"8","author":"LV Holmes","year":"2013","unstructured":"Holmes, L. V. et al. Determining the population frequency of the CFHR3\/CFHR1 deletion at 1q32. PloS one 8, e60352 (2013).","journal-title":"PloS one"},{"key":"10766_CR33","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.3777","volume":"18","author":"K Manthiram","year":"2017","unstructured":"Manthiram, K., Zhou, Q., Aksentijevich, I. & Kastner, D. L. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation. Nat. Immunol. 18, 832\u2013842 (2017).","journal-title":"Nat. Immunol."},{"key":"10766_CR34","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/jcm4010172","volume":"4","author":"L Celkova","year":"2015","unstructured":"Celkova, L., Doyle, S. L. & Campbell, M. NLRP3 inflammasome and pathobiology in AMD. J. Clin. Med. 4, 172\u2013192 (2015).","journal-title":"J. Clin. Med."},{"key":"10766_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jth.13925","volume":"16","author":"G Obermayer","year":"2018","unstructured":"Obermayer, G., Afonyushkin, T. & Binder, C. J. Oxidized low-density lipoprotein in inflammation-driven thrombosis. J. Thromb. Haemost.: JTH 16, 418\u2013428 (2018).","journal-title":"J. Thromb. Haemost.: JTH"},{"key":"10766_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nri.2016.63","volume":"16","author":"CJ Binder","year":"2016","unstructured":"Binder, C. J., Papac-Milicevic, N. & Witztum, J. L. Innate sensing of oxidation-specific epitopes in health and disease. Nat. Rev. Immunol. 16, 485\u2013497 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"10766_CR37","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jmb.2009.06.010","volume":"391","author":"AI Okemefuna","year":"2009","unstructured":"Okemefuna, A. I., Nan, R., Gor, J. & Perkins, S. J. Electrostatic interactions contribute to the folded-back conformation of wild type human factor H. J. Mol. Biol. 391, 98\u2013118 (2009).","journal-title":"J. Mol. Biol."},{"key":"10766_CR38","doi-asserted-by":"publisher","first-page":"e0166200","DOI":"10.1371\/journal.pone.0166200","volume":"11","author":"JP Hannan","year":"2016","unstructured":"Hannan, J. P., Laskowski, J., Thurman, J. M., Hageman, G. S. & Holers, V. M. Mapping the complement factor H-related protein 1 (CFHR1):C3b\/C3d interactions. PloS one 11, e0166200 (2016).","journal-title":"PloS one"},{"key":"10766_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep38250","volume":"6","author":"C-H Huang","year":"2016","unstructured":"Huang, C.-H. et al. Increased EMR2 expression on neutrophils correlates with disease severity and predicts overall mortality in cirrhotic patients. Sci. Rep. 6, 38250 (2016).","journal-title":"Sci. Rep."},{"key":"10766_CR40","doi-asserted-by":"publisher","first-page":"31823","DOI":"10.1074\/jbc.M402974200","volume":"279","author":"H-H Lin","year":"2004","unstructured":"Lin, H.-H. et al. Autocatalytic cleavage of the EMR2 receptor occurs at a conserved G protein-coupled receptor proteolytic site motif. J. Biol. Chem. 279, 31823\u201331832 (2004).","journal-title":"J. Biol. Chem."},{"key":"10766_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.imlet.2010.02.004","volume":"129","author":"M van Eijk","year":"2010","unstructured":"van Eijk, M. et al. Differential expression of the EGF-TM7 family members CD97 and EMR2 in lipid-laden macrophages in atherosclerosis, multiple sclerosis and Gaucher disease. Immunol. Lett. 129, 64\u201371 (2010).","journal-title":"Immunol. Lett."},{"key":"10766_CR42","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/cei.12679","volume":"182","author":"SM Lewis","year":"2015","unstructured":"Lewis, S. M. et al. Expression of CD11c and EMR2 on neutrophils: potential diagnostic biomarkers for sepsis and systemic inflammation. Clin. Exp. Immunol. 182, 184\u2013194 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"10766_CR43","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone, J. H. et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. New Engl. J. Med. 363, 221\u2013232 (2010).","journal-title":"New Engl. J. Med."},{"key":"10766_CR44","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates, M. et al. EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann. Rheum. Dis. 75, 1583\u20131594 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"10766_CR45","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. New Engl. J. Med. 377, 1119\u20131131 (2017).","journal-title":"New Engl. J. Med."},{"key":"10766_CR46","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1111\/his.13487","volume":"72","author":"SR Brix","year":"2018","unstructured":"Brix, S. R. et al. Organisation of lymphocytic infiltrates in ANCA-associated glomerulonephritis. Histopathology 72, 1093\u20131101 (2018).","journal-title":"Histopathology"},{"key":"10766_CR47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.smim.2015.03.013","volume":"27","author":"J Viola","year":"2015","unstructured":"Viola, J. & Soehnlein, O. Atherosclerosis\u2014a matter of unresolved inflammation. Semin. Immunol. 27, 184\u2013193 (2015).","journal-title":"Semin. Immunol."},{"key":"10766_CR48","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1093\/hmg\/ddq399","volume":"19","author":"LG Fritsche","year":"2010","unstructured":"Fritsche, L. G. et al. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). Hum. Mol. Genet. 19, 4694\u20134704 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"10766_CR49","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1080\/07853890601097030","volume":"38","author":"GS Hageman","year":"2006","unstructured":"Hageman, G. S. et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. Ann. Med. 38, 592\u2013604 (2006).","journal-title":"Ann. Med."},{"key":"10766_CR50","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1182\/blood-2007-09-109876","volume":"111","author":"M J\u00f3zsi","year":"2008","unstructured":"J\u00f3zsi, M. et al. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1\/CFHR3 deficiency. Blood 111, 1512\u20131514 (2008).","journal-title":"Blood"},{"key":"10766_CR51","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1186\/ar4016","volume":"14","author":"A Foltyn Zadura","year":"2012","unstructured":"Foltyn Zadura, A. et al. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome. Arthritis Res. Ther. 14, R185 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"10766_CR52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/jmg.2008.064766","volume":"46","author":"M-A Dragon-Durey","year":"2009","unstructured":"Dragon-Durey, M.-A. et al. The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome. J. Med. Genet. 46, 447\u2013450 (2009).","journal-title":"J. Med. Genet."},{"key":"10766_CR53","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0092-8674(00)80358-X","volume":"90","author":"HJ Lo","year":"1997","unstructured":"Lo, H. J. et al. Nonfilamentous C. albicans mutants are avirulent. Cell 90, 939\u2013949 (1997).","journal-title":"Cell"},{"key":"10766_CR54","doi-asserted-by":"publisher","first-page":"e1004824","DOI":"10.1371\/journal.pgen.1004824","volume":"10","author":"A Wartenberg","year":"2014","unstructured":"Wartenberg, A. et al. Microevolution of Candida albicans in macrophages restores filamentation in a nonfilamentous mutant. PLoS Genet. 10, e1004824 (2014).","journal-title":"PLoS Genet."},{"key":"10766_CR55","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1369\/0022155411416007","volume":"59","author":"A Francke","year":"2011","unstructured":"Francke, A., Herold, J., Weinert, S., Strasser, R. H. & Braun-Dullaeus, R. C. Generation of mature murine monocytes from heterogeneous bone marrow and description of their properties. J. Histochem. Cytochem. 59, 813\u20138257 (2011).","journal-title":"J. Histochem. Cytochem."},{"key":"10766_CR56","doi-asserted-by":"publisher","first-page":"e13519","DOI":"10.1371\/journal.pone.0013519","volume":"5","author":"C Siegel","year":"2010","unstructured":"Siegel, C. et al. Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi. PloS one 5, e13519 (2010).","journal-title":"PloS one"},{"key":"10766_CR57","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0378-1119(95)00360-I","volume":"162","author":"S K\u00fchn","year":"1995","unstructured":"K\u00fchn, S. & Zipfel, P. F. The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. Gene 162, 225\u2013229 (1995).","journal-title":"Gene"},{"key":"10766_CR58","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0014-5793(99)01554-9","volume":"462","author":"J Hellwage","year":"1999","unstructured":"Hellwage, J. et al. Functional properties of complement factor H-related proteins FHR-3 and FHR-4: binding to the C3d region of C3b and differential regulation by heparin. FEBS Lett. 462, 345\u2013352 (1999).","journal-title":"FEBS Lett."},{"key":"10766_CR59","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0162-3109(97)00075-1","volume":"38","author":"J Hellwage","year":"1997","unstructured":"Hellwage, J., Skerka, C. & Zipfel, P. F. Biochemical and functional characterization of the factor-H-related protein 4 (FHR-4). Immunopharmacology 38, 149\u2013157 (1997).","journal-title":"Immunopharmacology"},{"key":"10766_CR60","doi-asserted-by":"publisher","first-page":"e78617","DOI":"10.1371\/journal.pone.0078617","volume":"8","author":"HU Eberhardt","year":"2013","unstructured":"Eberhardt, H. U. et al. Human factor H-related protein 2 (CFHR2) regulates complement activation. PloS one 8, e78617 (2013).","journal-title":"PloS one"},{"key":"10766_CR61","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1365-2249.2006.03071.x","volume":"144","author":"M Oppermann","year":"2006","unstructured":"Oppermann, M. et al. The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native protein. Clin. Exp. Immunol. 144, 342\u2013352 (2006).","journal-title":"Clin. Exp. Immunol."},{"key":"10766_CR62","doi-asserted-by":"publisher","first-page":"I9","DOI":"10.1016\/j.vaccine.2008.11.021","volume":"26","author":"C Skerka","year":"2008","unstructured":"Skerka, C. & Zipfel, P. F. Complement factor H related proteins in immune diseases. Vaccine 26, I9\u2013I14 (2008).","journal-title":"Vaccine"},{"key":"10766_CR63","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1194\/jlr.P054569","volume":"56","author":"D Tsiantoulas","year":"2015","unstructured":"Tsiantoulas, D. et al. Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. J. lipid Res. 56, 440\u2013448 (2015).","journal-title":"J. lipid Res."},{"key":"10766_CR64","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.4049\/jimmunol.1701641","volume":"200","author":"RB Rudnick","year":"2018","unstructured":"Rudnick, R. B. et al. FHR5 binds to laminins, uses separate C3b and surface-binding sites, and activates complement on malondialdehyde-acetaldehyde surfaces. J. Immunol. 200, 2280\u20132290 (2018).","journal-title":"J. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10766-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10766-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T19:08:22Z","timestamp":1671217702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-10766-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["10766"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-10766-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"25 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.I., P.F.Z., and C.S. have filed a patent (DE10 2018 120 016.1). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2961"}}